Ir para o conteúdo principal

United States News Todas as matérias

Todas as matérias desta seção, das mais recentes às mais antigas — página 176 de 371.

Grafa

Rocket Lab wins $90M space force deal for geostationary satellites

Rocket Lab (NASDAQ:RKLB) has been awarded a $90 million contract by the U.S. Space Force’s Space Systems Command to design, build, and operate two geostationary orbit (GEO) satellites, signaling an expansion of the company’s manufacturing footprint into higher-altitude national security systems.

Leia mais: Rocket Lab wins $90M space force deal for geostationary satellites
Grafa

Ascentage Pharma reports positive pipeline data ahead of ASCO showcase

Ascentage Pharma (NASDAQ:AAPG) announced that abstracts for six of its clinical studies have been published ahead of the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, outlining early-phase therapeutic activity across its core pipeline of targeted oncology candidates.

Leia mais: Ascentage Pharma reports positive pipeline data ahead of ASCO showcase
Grafa

European regulators accept Teva and Medincell’s application for long-acting Schizophrenia injection

Teva Pharmaceutical Industries (NYSE:TEVA) and Medincell announced Thursday that the European Medicines Agency has accepted their Marketing Authorization Application for TEV-749, an investigational long-acting injectable formulation designed to treat adults living with schizophrenia.

Leia mais: European regulators accept Teva and Medincell’s application for long-acting Schizophrenia injection
Grafa

Hovnanian reports narrow Q2 loss as rising home contracts outpace margin pressures

Hovnanian Enterprises (NYSE:HOV) reported a small net loss for its second fiscal quarter that nevertheless came in ahead of internal operating guidance, as resilient homebuyer traffic helped the national homebuilder mitigate ongoing margin compression and affordability hurdles.

Leia mais: Hovnanian reports narrow Q2 loss as rising home contracts outpace margin pressures
Grafa
Health

Cosmos Health revenue rises 31% to record as U.S. expansion offsets widening net loss

Cosmos Health (NASDAQ:COSM) generated record revenue in the first quarter of 2026, driven by sustained distribution gains and market expansions, even as a shifting business mix and operational investments weighed on bottom-line profitability.

Leia mais: Cosmos Health revenue rises 31% to record as U.S. expansion offsets widening net loss
Grafa

Immix Biopharma reports 95% complete response rate in next-gen amyloidosis trial

Immix Biopharma (NASDAQ:IMMX) announced a highly favorable interim update from its ongoing registrational Phase 2 NEXICART-2 clinical trial, showing that its investigational CAR-T cell therapy, NXC-201, achieved a 95% complete response rate in patients with relapsed or refractory AL Amyloidosis.

Leia mais: Immix Biopharma reports 95% complete response rate in next-gen amyloidosis trial
Grafa

China approves HUTCHMED and Innovent combo therapy for advanced kidney cancer

HUTCHMED (NASDAQ:HCM) and Innovent Biologics jointly announced that China’s National Medical Products Administration has approved the combination of ELUNATE® (fruquintinib) and TYVYT® (sintilimab injection) for the treatment of adults with advanced kidney cancer.

Leia mais: China approves HUTCHMED and Innovent combo therapy for advanced kidney cancer
Grafa
Agriculture

Origin Agritech revenue drops 31.9% as deep cost cuts trim first-half loss

Origin Agritech (NASDAQ:SEED) reported a 31.9% decline in revenue for the first half of fiscal 2026, reflecting a deliberate structural transition within its commercial seed portfolio, though aggressive corporate cost-saving initiatives allowed the company to significantly narrow its net loss.

Leia mais: Origin Agritech revenue drops 31.9% as deep cost cuts trim first-half loss
Grafa
Retail

Ralph Lauren revenue tops estimates as FY sales pass $8B milestone

Ralph Lauren (NYSE:RL) reported fourth-quarter financial results that exceeded Wall Street estimates, driven by strong full-price selling trends and affluent consumers' appetite for premium apparel, pushing its full-year revenue past the $8 billion threshold for the first time in corporate history.

Leia mais: Ralph Lauren revenue tops estimates as FY sales pass $8B milestone
Grafa
Technology

Arqit Quantum first-half revenue climbs to $623,000 as software contracts expand

Arqit Quantum (NASDAQ:ARQQ) reported a significant increase in revenue for the first half of fiscal 2026, signaling early commercial momentum for its quantum-resistant encryption software despite low absolute sales volumes relative to its monthly overhead.

Leia mais: Arqit Quantum first-half revenue climbs to $623,000 as software contracts expand